BioCentury
ARTICLE | Company News

Sepracor, Versicor deal

October 9, 1995 7:00 AM UTC

SEPR created Versicor, a combinatorial chemistry subsidiary which will develop SEPR's chemical synthesis technologies to create chemical libraries for drug discovery. SEPR will provide $2 million annually to Versicor, with the intent of taking the company public in the future. ...